Skip to main content
. 2022 Aug 17;25(9):104975. doi: 10.1016/j.isci.2022.104975

Table 3.

Classification of MS ligands from datasets A-D according to the cross-validation predictions of the model trained including gene expression (MS(woexp):HPA + MS(wexp):INT) and its associated baseline model trained without this feature (MS(woexp + wexp))

With gene expression (MS(woexp):HPA + MS(wexp):INT)
Strong binder Weak binder Non-binder
Without gene expression (MS(woexp + wexp)) Strong binder Conserved Binder (CB)
(76.16%)
Unimproved Binder (UB)
(2.57%)
Lost Binder (LB)
(0.02%)
Weak binder Improved Binder (IB)
(7.77%)
Conserved Binder (CB) UnClassified peptide (UC)
(12.99%)
Non-binder Very Improved Binder (VIB)
(0.49%)
UnClassified peptide (UC) UnClassified peptide (UC)

The percentile rank score predictions of these two models were employed to classify the ligands. A peptide is considered to be a strong binder if its %rank score is ≤ 0.5, a weak binder if 0.5 < %rank score ≤ 2 and a non-binder if %rank score >2%. The number between parenthesis indicates the % of ligands in each category, e.g. Conserved Binder = 76.16%, UnClassified peptide = 12.99%.